3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
6
Gynecologic
2
CNS
1
Conditions
Brain Neoplasms
7
Central Nervous System Neoplasms
6
Breast Neoplasms
6
Pancreatic Neoplasms
5
Glioblastoma
5
Ovarian Neoplasms
4
Neoplasms
4
Medulloblastoma
4
Glioma
4
Sarcoma
3
Prostatic Neoplasms
3
Osteosarcoma
3
Melanoma
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Neuroectodermal Tumors, Primitive
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Microphthalmia, Isolated, with Coloboma 5
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Diffuse Intrinsic Pontine Glioma
2
Interventions
Filgrastim
14
Carboplatin
11
Peripheral Blood Stem Cell Transplantation
9
Ifosfamide
9
Etoposide
8
Flow Cytometry
5
Thiotepa
4
Therapeutics
4
Paclitaxel
4
Cyclophosphamide
4
Cisplatin
4
pegfilgrastim
3
Temozolomide
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Dexamethasone
3
Busulfan
3
sargramostim
2
liposomal amphotericin B
2
ixabepilone
2
etoposide phosphate
2
aldesleukin
2
Topotecan
2
Radiotherapy
2
Ondansetron
2
Methylprednisolone
2
Magnetic Resonance Spectroscopy
2
Itraconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
Gemcitabine
×
CNS
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled